Papatheodoridi, MargaritaMargaritaPapatheodoridiTUNG-HUNG SUHadziyannis, EmiliaEmiliaHadziyannisLiao, Chun-HsunChun-HsunLiaoOrfanidou, ΑfroditiΑfroditiOrfanidouHUNG-CHIH YANGZachou, KalliopiKalliopiZachouCHUN-JEN LIUKourikou, AnastasiaAnastasiaKourikouGatselis, NikolaosNikolaosGatselisManolakopoulos, SpiliosSpiliosManolakopoulosDalekos, GeorgeGeorgeDalekosJIA-HORNG KAOHadziyannis, StephanosStephanosHadziyannisPapatheodoridis, George VGeorge VPapatheodoridis2022-09-292022-09-292022-031478-3223https://scholars.lib.ntu.edu.tw/handle/123456789/623262Scarce data exist on the effect of nucleos(t)ide analogue (NA) discontinuation on hepatocellular carcinoma (HCC) risk in HBeAg-negative chronic hepatitis B (CHBe-). Therefore, we assessed whether HCC risk is increased in non-cirrhotic CHBe- patients who discontinue compared to those remaining on NAs.endiscontinuation; entecavir; liver cancer; nucleoside analogue; tenofovirjournal article10.1111/liv.15128348901202-s2.0-85121435469WOS:000731828400001https://scholars.lib.ntu.edu.tw/handle/123456789/619200